Luteotropic effects of human chorionic gonadotropin administered 7.5 days after synchronous estrous induction in Morada Nova ewes

Anim Reprod Sci. 2020 Dec:223:106644. doi: 10.1016/j.anireprosci.2020.106644. Epub 2020 Nov 2.

Abstract

This study was conducted in ewes to assess effects of human chorionic gonadotropin (hCG) administration after imposing an estrous induction treatment regimen. Ewes (n = 115) were treated with a 60 mg medroxyprogesterone-intravaginal-sponge for 6 d plus 200 IU of equine chorionic gonadotropin (eCG) im and 37.5 μg d-cloprostenol im 36 h before sponge removal (Day 0). After natural mating, ewes having at least one corpus luteum (CL; n = 108) were administered either 1 mL of saline (G-Control; n = 53) or 300 IU of hCG (G-hCG; n = 55) on Day 7.5 after sponge removal (Day 0). Ovarian ultrasonography and blood collection were performed on Days 7.5, 13.5, 17.5, 21.5, and 30.5. Accessory CL (aCL) were observed in 81.5 % (G-hCG) and 0.0 % (G-Control) of ewes (P = 0.0001). Diameter, area, and volume of luteal tissue were greater (P < 0.05) in G-hCG from Day 13.5 to 30.5. Progesterone (P4) concentrations were greater (P < 0.05) on Days 13.5, 17.5, 21.5 and 30.5 for ewes of the G-hCG group. Pregnancy percentage was similar (P = 0.25) between groups [47.1 % (G-control) compared with 60.0 % (G-hCG)], although total number of lambs produced by estrous synchronized ewes was greater (P = 0.005) in ewes of the G-hCG group (90.9 % compared with 66.0 %). In conclusion, hCG administration 7.5 days after sponge removal from Morada Nova ewes during the non-breeding season is an effective treatment to induce aCL formation, improve luteal tissue biometry and P4 concentrations, and to enhance the total number of lambs born.

Keywords: Accessory corpora lutea; Luteal blood flow; Luteal vascularization; Ovarian ultrasonography; Progesterone; hCG.

Publication types

  • Randomized Controlled Trial, Veterinary

MeSH terms

  • Animals
  • Chorionic Gonadotropin* / administration & dosage
  • Chorionic Gonadotropin* / pharmacology
  • Cloprostenol / pharmacology
  • Contraceptives, Oral, Hormonal / pharmacology
  • Corpus Luteum* / drug effects
  • Drug Administration Schedule
  • Estrus Synchronization* / drug effects
  • Female
  • Luteolytic Agents / pharmacology
  • Medroxyprogesterone / administration & dosage
  • Medroxyprogesterone / pharmacology
  • Pregnancy
  • Progesterone / blood
  • Reproductive Control Agents / administration & dosage
  • Reproductive Control Agents / pharmacology
  • Sheep*

Substances

  • Chorionic Gonadotropin
  • Cloprostenol
  • Contraceptives, Oral, Hormonal
  • Luteolytic Agents
  • Medroxyprogesterone
  • Progesterone
  • Reproductive Control Agents